Press release
A Potential Synthetic Vaccine Adjuvant for Tuberculosis Vaccines
Plant-Based Protein Expression Market
Protein expression systems are the foundation of modern biotechnology, enabling the production of therapeutic proteins, enzymes, and vaccines. While bacterial, yeast, and mammalian cell expression systems dominate, plant-based protein expression platforms are emerging as a sustainable, scalable, and cost-effective alternative. Plants such as tobacco, maize, and rice can be genetically engineered to produce recombinant proteins, antibodies, and vaccines with advantages in speed, safety, and affordability.
The global plant-based protein expression market is gaining traction as pharmaceutical, biotechnology, and agricultural companies seek alternatives that can lower production costs and reduce reliance on complex mammalian cell cultures. With growing demand for biologics and vaccines, the next decade is expected to witness significant expansion of plant-based expression technologies.
Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/72640
Market Overview
• The global plant-based protein expression market size in 2024 is estimated at USD 610 million.
• It is projected to reach USD 1.6 billion by 2034, growing at a CAGR of 10.2 % during the forecast period.
• Growth is driven by rising demand for biologics, expanding use of molecular farming, and growing interest in sustainable biomanufacturing solutions.
Key Market Drivers:
• Cost-effectiveness compared to mammalian cell expression systems.
• Scalability for mass production of vaccines and therapeutic proteins.
• Elimination of human/animal pathogen contamination risks.
• Increasing focus on sustainable and green biotechnology platforms.
Key Challenges:
• Limited regulatory precedent and pathway complexities.
• Technical barriers in protein yield consistency and purification.
• Competition from established expression systems like CHO (Chinese hamster ovary) cells.
Leading Players:
iBio Inc., Medicago (Mitsubishi Chemical), Kentucky Bioprocessing, Icon Genetics, Leaf Expression Systems, PlantForm, and Fraunhofer IME.
Segmentation Analysis
The plant-based protein expression market can be segmented as follows:
By Host Plant
• Tobacco (Nicotiana benthamiana)
• Cereals (Maize, Rice, Barley)
• Legumes
• Other Plants
By Product Type
• Recombinant Antibodies
• Enzymes
• Vaccines & Antigens
• Therapeutic Proteins
• Others
By Application
• Pharmaceuticals & Biologics
• Industrial Enzymes
• Research Applications
• Veterinary Medicines
By Expression Technology
• Transient Expression
• Stable Transgenic Expression
• Chloroplast Expression
• Viral Vector-mediated Expression
By End-Use
• Pharmaceutical & Biotechnology Companies
• Contract Manufacturing Organizations (CMOs/CDMOs)
• Academic & Research Institutes
• Agricultural Biotechnology Firms
Summary:
Tobacco plants dominate as the preferred host due to rapid growth cycles and high biomass yield. Recombinant antibodies and vaccine antigens are the largest product segments, reflecting strong demand for affordable biologics. Transient expression systems remain the most widely adopted due to speed and flexibility, though stable transgenic methods are gaining attention for long-term applications.
Explore Full Report here:
https://exactitudeconsultancy.com/reports/72640/plant-based-protein-expression-market
Regional Analysis
North America
• Largest market, supported by strong biotech ecosystems in the U.S. and Canada.
• Government funding for molecular farming and plant-based vaccine development fuels adoption.
Europe
• Active research in Germany, the UK, and the Netherlands.
• EU-funded projects driving regulatory frameworks for plant-made pharmaceuticals.
Asia-Pacific (APAC)
• Expected to record the fastest CAGR (~12.5 %) through 2034.
• China, Japan, and India investing in plant biotechnology for vaccines, including pandemic preparedness.
• Expanding pharmaceutical outsourcing strengthens the region's role.
Middle East & Africa (MEA)
• Early adoption, with potential for low-cost vaccine manufacturing in future.
• Gulf nations investing in biotech innovation hubs.
Latin America
• Brazil and Argentina leveraging strong agricultural bases to explore molecular farming applications.
• Gradual expansion of biotech partnerships with North America and Europe.
Regional Summary:
North America and Europe dominate in research and commercialization, while Asia-Pacific is the fastest-growing hub, expected to lead in both manufacturing scalability and cost-effective production.
Market Dynamics
Growth Drivers
1. Rising demand for affordable biologics and biosimilars.
2. Expansion of molecular farming as a green biotechnology approach.
3. Increasing investments in plant-made vaccines, especially for pandemics.
4. Growing adoption by CMOs/CDMOs for cost-effective production.
Key Challenges
• Regulatory hurdles due to limited precedent in plant-derived pharmaceuticals.
• Technical challenges in achieving consistent protein yields.
• Competition from mammalian expression systems with established clinical use.
Latest Trends
• Development of plant-based COVID-19 vaccines as proof-of-concept for rapid response.
• Integration of synthetic biology to enhance expression yields and protein folding.
• Rising partnerships between pharma and agri-biotech firms.
• Expansion of dual-use applications - from therapeutic proteins to industrial enzymes.
Get Your Exclusive Offer with up to 10% Discount :
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=72640
Competitor Analysis
Major Players:
• iBio Inc.
• Medicago Inc. (Mitsubishi Chemical subsidiary)
• Kentucky Bioprocessing (Reynolds American/BAT subsidiary)
• Icon Genetics GmbH
• Leaf Expression Systems
• PlantForm Corporation
• Fraunhofer Institute for Molecular Biology and Applied Ecology (IME)
Competitive Summary:
The market is moderately consolidated, with a handful of pioneering companies holding strong intellectual property positions in transient and viral vector-based expression systems. Larger pharma companies are increasingly collaborating with these innovators to diversify biologics manufacturing platforms. Strategic partnerships, government-backed research programs, and advances in synthetic biology are fueling competition.
Conclusion
The plant-based protein expression market is projected to grow from USD 610 million in 2024 to USD 1.6 billion by 2034, at a CAGR of 10.2 %.
This report is also available in the following languages : Japanese (植物由来タンパク質発現市場), Korean (식물 기반 단백질 발현 시장), Chinese (植物蛋白表达市场), French (Marché de l'expression des protéines végétales), German (Markt für pflanzliche Proteinexpression), and Italian (Mercato dell'espressione proteica a base vegetale), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/72640
Our More Reports:
Plasmid DNA Manufacturing Market
https://exactitudeconsultancy.com/reports/72420/plasmid-dna-manufacturing-market
Next Generation Drug Conjugates Market
https://exactitudeconsultancy.com/reports/72418/next-generation-drug-conjugates-market
Lipid Nanoparticle Manufacturing Market
https://exactitudeconsultancy.com/reports/72416/lipid-nanoparticle-manufacturing-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release A Potential Synthetic Vaccine Adjuvant for Tuberculosis Vaccines here
News-ID: 4201774 • Views: …
More Releases from Exactitude Consultancy
Analysis of the Clinical Trial Pipeline for Complement Inhibitors: 40+ Important …
The global Complement Inhibitors Market is gaining strong momentum as biotechnology and pharmaceutical industries focus on therapies targeting the complement system-an integral part of the immune response. Complement inhibitors are designed to regulate excessive immune activation, which is implicated in rare diseases, autoimmune conditions, and chronic inflammatory disorders. They have become vital therapeutic options in conditions such as paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), age-related macular degeneration…
CAR-T Cell Therapies Market : White Space Opportunities in Next-Generation
Introduction
Chimeric Antigen Receptor T-cell (CAR-T) therapy is revolutionizing cancer treatment by enabling a patient's immune system to identify and destroy malignant cells with unprecedented precision. Unlike chemotherapy or radiation, CAR-T therapies offer personalized, targeted, and durable responses, often in patients with otherwise treatment-resistant cancers.
The past decade has seen regulatory approvals of several CAR-T therapies across the U.S., Europe, and Asia, demonstrating both strong efficacy and commercial potential. Yet, this is…
Information about immune checkpoint inhibitors for colorectal cancer is revealed …
The global Immune Checkpoint Inhibitors Clinical Trials Analysis Market is expanding rapidly as oncology research increasingly focuses on immunotherapy as a frontline treatment for cancer. Immune checkpoint inhibitors (ICIs) target regulatory pathways such as PD-1, PD-L1, and CTLA-4, unlocking the immune system's ability to fight tumors. With their proven success in melanoma, lung, kidney, and head & neck cancers, ICIs represent one of the most transformative developments in modern oncology.
Download…
A new Myeloid Cell Targeting Therapeutics participant joins the clinic | ApexOnc …
The global Myeloid Cell Targeting Therapeutics Market is gaining significant traction as immuno-oncology research increasingly recognizes the role of myeloid cells in cancer progression, immune evasion, and chronic inflammation. Myeloid cells-including macrophages, dendritic cells, and myeloid-derived suppressor cells (MDSCs)-play dual roles: while essential for immune defense, they also contribute to tumor growth and resistance to therapies when dysregulated.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72647
Targeting these cells with…
More Releases for Expression
Expression Vectors Market - Precision Engineering: Drive Gene Expression with In …
Newark, New Castle, USA: The "Expression Vectors Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Expression Vectors Market: https://www.growthplusreports.com/report/expression-vectors-market/7928
This latest report researches the industry structure, sales, revenue,…
Protein Expression Market - Driving Progress in Protein with Cutting-edge Expres …
Newark, New Castle, USA: The "Protein Expression Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Protein Expression Market: https://www.growthplusreports.com/report/protein-expression-market/7739
This latest report researches the industry structure, sales, revenue,…
Expression Vectors Market - Seamless Transcription, Unleashed Discoveries: Revol …
Newark, New Castle, USA - new report, titled Expression Vectors Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Expression Vectors market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Expression Vectors market. The report offers an overview of the market, which…
Global Protein Expression Systems Market, By Expression System (Mammalian Expres …
The global protein expression systems market size was valued at US$ 1.2 billion in 2017, and is expected to witness a CAGR of 11.1% over the forecast period (2023 - 2032
In branches of science such as biochemistry, molecular biology, and protein research, which depend on functioning proteins for their investigations, protein expression has emerged as a crucial laboratory tool. The technology can also deliver the enzymes or substrates needed for…
Protein Expression Market - North America is the Largest Market for the Protein …
New York, April 25: Market Research Engine has published a new report titled as “Protein Expression Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020”
The process in which proteins are synthesized, modified and regulated in a living organism is known as a Protein Expression. This is also used to study the cells or tissues for the presence of one or more protein. North America…
Global Protein Expression Market
The Protein Expression Market reportprovides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Protein expression is a technique in which proteins are synthesized, modified and regulated in living organism. Protein expression is used to study for the presence of one or more proteins in the…
